Trivium Point Advisory LLC Sells 502 Shares of MetLife, Inc. $MET

Trivium Point Advisory LLC lowered its position in MetLife, Inc. (NYSE:MET) by 3.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,938 shares of the financial services provider’s stock after selling 502 shares during the quarter. Trivium Point Advisory LLC’s holdings in MetLife were worth $1,201,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Brighton Jones LLC increased its stake in MetLife by 9.0% in the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock valued at $347,000 after acquiring an additional 351 shares during the period. Versant Capital Management Inc raised its stake in shares of MetLife by 151.4% in the first quarter. Versant Capital Management Inc now owns 1,584 shares of the financial services provider’s stock valued at $127,000 after acquiring an additional 954 shares during the last quarter. GAMMA Investing LLC raised its position in MetLife by 8,789.6% in the 1st quarter. GAMMA Investing LLC now owns 815,889 shares of the financial services provider’s stock valued at $65,508,000 after purchasing an additional 806,711 shares during the last quarter. Fifth Third Wealth Advisors LLC boosted its stake in MetLife by 14.3% in the first quarter. Fifth Third Wealth Advisors LLC now owns 12,768 shares of the financial services provider’s stock worth $1,025,000 after purchasing an additional 1,601 shares in the last quarter. Finally, American National Bank & Trust grew its holdings in shares of MetLife by 128.4% during the first quarter. American National Bank & Trust now owns 603 shares of the financial services provider’s stock worth $48,000 after purchasing an additional 339 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors.

MetLife Stock Up 0.4%

MetLife stock opened at $82.37 on Wednesday. The firm has a market capitalization of $54.78 billion, a price-to-earnings ratio of 13.96, a PEG ratio of 0.74 and a beta of 0.87. The company’s 50 day simple moving average is $78.88 and its 200 day simple moving average is $78.18. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $89.05.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing the consensus estimate of $2.32 by ($0.30). The firm had revenue of $17.34 billion during the quarter, compared to analyst estimates of $18.58 billion. MetLife had a return on equity of 19.88% and a net margin of 5.83%.The company’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same quarter last year, the business posted $2.28 earnings per share. As a group, sell-side analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th were paid a $0.5675 dividend. This represents a $2.27 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Tuesday, August 5th. MetLife’s payout ratio is presently 38.47%.

Analyst Ratings Changes

A number of research analysts recently issued reports on MET shares. Morgan Stanley cut their price target on MetLife from $98.00 to $94.00 and set an “overweight” rating for the company in a report on Monday, August 18th. Barclays boosted their target price on shares of MetLife from $88.00 to $94.00 and gave the stock an “overweight” rating in a research note on Monday, July 7th. Cowen reissued a “buy” rating on shares of MetLife in a research note on Friday, August 22nd. UBS Group dropped their price objective on shares of MetLife from $94.00 to $91.00 and set a “buy” rating for the company in a research report on Thursday, August 7th. Finally, Wells Fargo & Company reiterated an “overweight” rating and issued a $97.00 price objective (up from $94.00) on shares of MetLife in a research report on Thursday, July 10th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $94.64.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.